In contrast, nuclear truncation does not affect the ability to detect high-level amplifications, as previously shown in cytohistological comparisons of HER-2 FISH analysis in breast cancer (Bozzetti et al, 2002; Gu et al, 2005). Here, ERBB2 is linked to breast carcinoma.